glp 1 a GLP-1s for Weight Loss: What You Need to Know Decoding GLP-1 Weight Loss Medications

The bottom line: Our findings suggest that GLP-1RA and SGLT2i (and especially SGLT2i with the lowest number needed to treat (NNT) for nearly all study outcomes) may be the preferred glucose-lowering agents for cardiovascular risk reduction in patients at moderate risk for CVD, building on and consistent with existing RCT evidence in the high-risk population. This report highlights potential preference for GLP-1 drugs as a first-line treatment for Type 2 diabetes related to its cardioprotective effect

doi: 10.1007/s10311-017-0648-9 31 DobrikovaA.ApostolovaE.HanA.YotsovaE.BorisovaP.SperdouliI.et al

Interventions for sexual dysfunction following treatments for cancer

This included 166 original reports, 45 review articles, and not a single study tagged as a clinical trial